Event Gaps: DeepSeek's picks for 2026-09-28
DeepSeek picked AKAM, GRAL, BB, COST, INLF for a 1-day horizon. Intraday alpha vs SPY: +6.65%. Picks with positive alpha: 80%.
| Experiment | Event Gaps |
|---|---|
| Model | DeepSeek |
| Prompt version | event-gap-v9 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-09-25 |
| Measured to | 2026-09-28 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | +6.65% |
| Picks with positive alpha | 80% |
| Benchmark return | -0.36% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | AKAM | up | -3.42% | -3.42% | 90% | -3.06% | No |
| 2 | GRAL | up | +2.89% | +2.89% | 85% | +3.25% | Yes |
| 3 | BB | up | +10.83% | +10.83% | 75% | +11.19% | Yes |
| 4 | COST | down | -0.16% | -0.16% | 70% | +0.20% | Yes |
| 5 | INLF | up | +21.35% | +21.35% | 65% | +21.70% | Yes |
The model's market view
US equity futures are modestly higher Friday morning as falling oil prices and easing bond-market stress support risk appetite after a sharp week of Treasury yield spikes. S&P 500 futures are up about 0.3% and Nasdaq 100 futures are up about 0.6%, with semiconductors and AI-infrastructure names leading premarket gains. The Akamai-Anthropic cloud deal is the standout corporate event, lifting the entire AI infrastructure complex. Costco's better-than-expected Q4 results and BlackBerry's guidance raise add to a constructive but selective tape. With the market rewarding clear catalysts and punishing disappointment, I favor high-conviction, event-driven names that can generate alpha independent of the benchmark.
Why each pick
AKAM
Akamai announced a seven-year, $11.6 billion cloud services commitment from Anthropic, with provisions allowing expansion by up to an additional $9 billion for a potential total of ~$20 billion. The deal includes a warrant for Anthropic to buy up to 5% of Akamai at $111.33 per share. The stock surged ~21% in premarket trading to around $133.82. This is a fundamental re-rating catalyst that transforms Akamai into a hypergrowth AI infrastructure play. Risks: the stock has already gapped up significantly, so some profit-taking is possible; execution risk on the large infrastructure buildout; the deal was disclosed after Thursday's close, so the full market impact may not be fully priced.
GRAL
Grail received a favorable vote from an FDA advisory committee for its Galleri multi-cancer early detection test. The stock surged 55% through Friday morning after the vote, and multiple analysts raised price targets. Mizuho lifted its target to $100 from $65. The stock closed at $125.21 on Thursday, up 15.38%. The favorable committee vote is a major regulatory milestone that could open up significant adoption and insurer coverage. Risks: the efficacy vote was close, reflecting ongoing concerns about effectiveness; the stock has already run up significantly and is vulnerable to profit-taking; final FDA approval is still pending and could face delays.
BB
BlackBerry reported Q2 FY27 adjusted EPS of $0.07 versus the $0.04 consensus and revenue of $163.3 million, up 26% year-over-year, driven by record QNX automotive software revenue. The company raised its full-year revenue guidance to $616-$636 million and posted an 81% increase in adjusted EBITDA. The stock jumped 4.18% on Thursday to close at $8.73 and was trading higher in Friday's premarket around $8.91. The beat-and-raise quarter provides fundamental support for continued momentum. Risks: the stock is a small-cap with higher volatility; the broader market's narrow breadth could limit follow-through; the 121% year-to-date gain means some investors may look to lock in profits.
COST
Costco reported better-than-expected Q4 fiscal 2026 results, with net sales up 11.2% to $93.9 billion and adjusted EPS of $6.75 versus the $6.53 consensus. However, the stock fell 0.91% in after-hours trading to $896.48, and some analysts trimmed price targets despite maintaining bullish ratings. The market reaction suggests that the beat was largely priced in and that guidance may have disappointed. Risks: the stock trades at a premium valuation and could continue to see profit-taking; rising bond yields are pressuring high-multiple consumer staples names.
INLF
INLIF Limited reported unaudited first-half fiscal 2026 results with a 26.01% net revenue rise, driven by the introduction of its intelligent equipment business. The stock surged 94.58% in premarket trading to $5.74. This is a small-cap Chinese manufacturer of automated manipulator arms with high volatility. The strong revenue growth is a clear catalyst, but the stock trades near its 52-week low and has limited analyst coverage. Risks: extreme volatility, low liquidity, and the potential for a sharp reversal after such a large premarket gain; the broader market may not sustain enthusiasm for a micro-cap name.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| GPT-5.6 Sol | AKAM, MSFT, NKE, CMCSA, COST | +0.20% | 60% |
| Claude Opus 5.5 | MU, MIRM, AMD, INTC, CCL | -1.56% | 20% |
| Gemini 1.5 Pro | STFS, NKE, WKEY, MRK, WDAY | +1.48% | 80% |
| Muse Spark 1.1 | MIRM, INCY, COST, NKE, KNDI | +7.09% | 80% |
| Perplexity | KNDI, MTN, JEF, POCI, GNS | +5.01% | 40% |
| Grok 4.5 | AKAM, SCHL, WTTR, PRME, MU | +0.42% | 60% |
Written up on ForecastNest Insights: Event Gaps: DeepSeek's picks for 2026-09-28.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.